Health
Economic burden of acute myeloid leukemia treatment | JBM – Dove Medical Press
What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations
AML: A Rare and Costly Cancer
Acute myeloid leukemia (AML) arises in the bone marrow from the abnormal clonal expansion of myeloid blood cell precursors. Leukemic blast cells are found in the circulating blood as well as in the bone marrow, where they disrupt normal blood cell production, leading to myelosuppression.1 Consequences of AML include anemia, with weakness and pallor, thrombocytopenia, resulting in bleeding, and leukopenia, leading to fever and infection.
AML, which accounts for about…
-
Business22 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News22 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business18 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News21 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses